Recent

% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • flyingfishroe flyingfishroe Dec 4, 2006 10:06 PM Flag

    latest delay

    I have two quetions.Someone please let me know,
    1.(about)300 pations are in the trial.Is that means 150 are with placebo and 150 are with Glufosfamide?
    2.Does placebo,in this trial,mean BSC(=best supportive care)? Is that like the following explanation mentioned?

    (The following is from THLD web)
    Phase 3 Trial Details
    The phase 3 trial will evaluate approximately 300 previously-treated patients with metastatic pancreatic cancer who receive glufosfamide (4500mg/m2) once every 3 weeks or best supportive care (BSC). Best supportive care includes all medical or surgical interventions that a pancreatic cancer patient should receive to palliate the cancer but excludes treatment with systemic therapies intended to kill the cancer cells.

 
THLD
4.10-0.20(-4.65%)Apr 24 4:00 PMEDT